Itai Kela

Itai Kela, PhD, MBA, is a highly experienced professional in the field of health technology and innovation. Currently serving as the Director of Global External Innovation Outreach at Novo Nordisk, Itai has previously held significant roles including Director of Global External Innovation & Scientific Licensing at Ferring Pharmaceuticals and Head of the Healthtech Sector at the Israel Innovation Authority. Itai's background also includes leadership positions at NRGene Ltd., CGA - Personalized Medicine Technology, Stem Cell Medicine, and Protalix Biotherapeutics. Educational qualifications encompass a Post Doctorate at Stanford University, a PhD and Master's Degree from the Weizmann Institute of Science, and a Bachelor’s Degree from The Hebrew University of Jerusalem, all focusing on immunotherapy and personalized medicine.